LPL Financial
SANA icon

LPL Financial’s Sana Biotechnology SANA Stock Holding History

LPL Financial’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.1K Sell
19,812
-5,863
-23% -$23.1K ﹤0.01% 5761
2025
Q4 		$104K Buy
+25,675
New +$115K ﹤0.01% 5586
2025
Q1 		– Sell
-13,140
Closed -$21.4K – 5491
2024
Q4 		$21.4K Sell
13,140
-11,100
-46% -$33.1K ﹤0.01% 5194
2024
Q3 		$101K Buy
24,240
+200
+0.8% +$1.05K ﹤0.01% 4889
2024
Q2 		$131K Sell
24,040
-885
-4% -$7.05K ﹤0.01% 4680
2024
Q1 		$249K Buy
24,925
+2,450
+11% +$18.4K ﹤0.01% 4349
2023
Q4 		$91.7K Buy
22,475
+2,150
+11% +$7.92K ﹤0.01% 4568
2023
Q3 		$78.7K Sell
20,325
-300
-1% -$1.61K ﹤0.01% 4459
2023
Q2 		$123K Buy
+20,625
New +$119K ﹤0.01% 4284
2022
Q2 		– Sell
-12,330
Closed -$102K – 4521
2022
Q1 		$102K Buy
+12,330
New +$99.7K ﹤0.01% 3977

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

LPL Financial's SANA Position: Q1 2026 in Review

LPL Financial reduced its Sana Biotechnology (SANA) stake by 23% in Q1 2026, selling an estimated $23.1K and leaving 19,812 shares worth $57.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5761.

LPL Financial first reported a position in SANA in Q1 2022 and has held it in 10 quarters since. The position peaked at $249K in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • LPL Financial held 19,812 shares of Sana Biotechnology worth $57.1K as of Q1 2026.
  • LPL Financial sold 5,863 Sana Biotechnology shares in Q1 2026, an estimated $23.1K.
  • Sana Biotechnology made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5761 holding.
  • LPL Financial first reported a position in Sana Biotechnology in Q1 2022 and has held it in 10 quarters since.
  • LPL Financial's Sana Biotechnology position peaked at $249K in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.